Thursday, July 3, 2025

Aurora Cannabis Sued By CTT Pharma Over Denial Of Contractual Commitments

It seems Aurora Cannabis (TSX: ACB) (NYSE: ACB) has found itself in some hot water. It was announced this morning by CTT Pharmaceutical Holdings that a statement of claim has been filed against the cannabis giant in the Ontario Superior Court of Justice in relation to what amounts to a breach of contract related to sublingual cannabis-infused strips.

CTT Pharma is currently seeking compensation for Aurora’s denial of contractual commitments. The company has alleged that it is owed expenses, royalties, lost royalties and damages in connection with an agreement entered into in October 2019. Despite what is referred to as “rapid sales” CTT has claimed that Aurora has denied further resources for the partnership and has since claimed that the original agreement is no longer in force.

The original commercialization agreement was entered into between CTT Pharma and that of CanniMed, whom was subsequently acquired by Aurora. Following the acquisition, its stated that the two parties worked towards commercialization, with the first product run selling out within 60 days of launch.

To add further salt to the wound, the company has since appointed Dr Shane Morris, the former Chief Product Officer at Aurora to its advisory board.

Financial figures being sought in connection with the lawsuit were not released by the company. Aurora Cannabis has yet to respond to the announcement of the filing.

Aurora Cannabis last traded at $9.36 on the NYSE.


Information for this briefing was found via Sedar and Aurora Cannabis. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold Drilling Scaled to 60,000 Meters: How Big Can This Get? | Roger Rosmus – Goliath Resources

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Recommended

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Goliath Resources Expands 2025 Drill Program To 60,000 Metres

Related News

Booth Dumps Majority Of Position In Aurora Cannabis

What do you do when a founder dumps his shares on the open market? Thats...

Monday, March 16, 2020, 08:08:07 AM

Aurora Cannabis Posts Q1 2022 Revenues Of $60.1 Million, Net Loss

Aurora Cannabis (TSX: ACB) last night released its first quarter financial results, posting revenues of...

Wednesday, November 10, 2021, 07:38:33 AM

Aurora Cannabis Converts 99% of $230 Million Convertible Debenture Into 69 Million Shares

Aurora Cannabis (TSX: ACB) (NYSE: ACB) announced this morning that their early conversion option on...

Monday, November 25, 2019, 09:37:40 AM

Aurora Cannabis Posts Annual Gross Revenues of $271 Million

Aurora Cannabis (TSX: ACB) (NYSE: ACB) posted its fourth quarter financials after the bell today,...

Wednesday, September 11, 2019, 05:58:51 PM

Battley Leaves Executive Role at Aurora Cannabis

Aurora Cannabis (TSX: ACB) (NYSE: ACB) has seen its chief corporate officer Cam Battley step...

Saturday, December 21, 2019, 05:46:13 PM